Veterinary Antimicrobial Susceptibility Testing Market To Reach $2.26 Billion By 2033

Veterinary Antimicrobial Susceptibility Testing Market Growth & Trends

The global veterinary antimicrobial susceptibility testing market size is expected to reach USD 2.26 billion by 2033, registering a CAGR of 8.06% from 2025 to 2033, according to a new report by Grand View Research, Inc. Rising need to curtail AMR in food animals and zoonosis are key drivers for this market. Animals used for food are most susceptible to Antimicrobial Resistance (AMR) as to ensure a quality yield, the animal owners often feed them. These drugs, although they ensure that the animals remain healthy from any infection, may lead to the development of resistance from a variety of microbes over some time. AMR is a growing occurrence in food animals, threatening their health and possibly human health.

A January 2024 study in Nature Communications explored the antimicrobial resistance in food animals in various countries like China, India, Brazil, Chile, and others. Drug resistance of different antimicrobials was studied in species like E.coli & non-typhoidal Salmonella. The study concluded tetracycline had the highest resistance prevalence of 59% in E.coli and 54% in non-typhoidal Salmonella. However, the lowest resistance prevalence was found for cefotaxime, i.e., 33% & 19%, respectively, in E.coli & non-typhoidal Salmonella. The surveillance study also classified the AMR into regional locations. For instance, pathogens from 78% of locations studied in African & South American regions were resistant to penicillin or tetracyclines. On the other hand, in Asia, pathogens from 77% of locations were resistant to penicillin or sulphonamides.

This highlights the significant prevalence of antimicrobial resistance in food animals across the globe, increasing the emphasis on the urgent need for effective antimicrobial susceptibility testing products. As AMR threatens animal and human health, a rise in demand for appropriate testing solutions to combat this resistance will be experienced. The demand for advanced testing technologies among veterinary professionals to accurately assess antimicrobial susceptibility patterns will increase, driving the market growth.

Artificial Intelligence (AI) is another potential driving factor for the market owing to industry developments focused on integrating AI into veterinary AST. For instance, in November 2023, the University of Oxford's Oxford Martin Programme on Antimicrobial Resistance Testing displayed AI's capability of detecting antimicrobial resistance in only 30 minutes. Such developments paint a promising picture of market growth.

 Request a free sample copy or view report summary: Veterinary Antimicrobial Susceptibility Testing Market Report

Veterinary Antimicrobial Susceptibility Testing Market Report Highlights

• The production segment led the market with the largest revenue share of 65.86% in 2024. The companion segment is estimated to grow at the fastest CAGR from 2024 to 2033.

• The automated AST instruments segment accounted for the largest market revenue share of 43.33% 2024. The disks & plates segment is expected to grow at the fastest CAGR over the forecast period.

• The veterinary reference laboratories segment accounted for the largest market revenue share in 2024. The veterinary research institutes segment is expected to grow at the fastest CAGR from 2025 to 2033.

• North America dominated the global veterinary antimicrobial susceptibility testing market with the largest revenue share of 34.59% in 2024. The veterinary antimicrobial susceptibility testing market in the U.S. accounted for the largest market revenue share in North America in 2024.

• The veterinary antimicrobial susceptibility testing market in Asia Pacific is expected to grow at the fastest CAGR over the forecast period. The China veterinary antimicrobial susceptibility testing market is witnessing new growth opportunities due to public and industry awareness of AMR and rising technological adoption.

Veterinary Antimicrobial Susceptibility Testing Market Segmentation

Grand View Research has segmented global veterinary antimicrobial susceptibility testing market report based on animal, product, end-use and region:

Veterinary Antimicrobial Susceptibility Testing Animal Outlook (Revenue, USD Million, 2021 - 2033)

• Production Animal

  • Cattle

  • Poultry

  • Pigs

  • Others

• Companion Animal

  • Dogs

  • Cats

  • Horses

  • Others

Veterinary Antimicrobial Susceptibility Testing Product Outlook (Revenue, USD Million, 2021 - 2033)

• Disks & Plates

• Culture Media

• Accessories & Consumables

• Automated AST Instruments

Veterinary Antimicrobial Susceptibility Testing End-use Outlook (Revenue, USD Million, 2021 - 2033)

• Veterinary Reference Lab

• Vet Research Institutes

• Others

Veterinary Antimicrobial Susceptibility Testing Region Outlook (Revenue, USD Million, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • Thailand

  • South Korea

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • UAE

  • Saudi Arabia

  • Kuwait

  • Qatar

  • Oman

List of Key Players of Veterinary Antimicrobial Susceptibility Testing Market

• BioMérieux SA

• Becton, Dickinson and Company

• Synbiosis

• Thermo Fisher Scientific

• Bruker Corporation

• Mast Group Ltd

• Condalab

• Bioguard Corporation

• Liofilchem S.r.l.

• HiMedia Laboratories

• Bio-Rad Laboratories